Aspen Pharmacre Hl ADR (APNHY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 79,179 | 374,393 | 441,161 | 570,552 | 432,798 |
| Depreciation Amortization | 115,104 | 105,556 | 100,843 | 112,715 | 107,776 |
| Accounts receivable | -42,592 | -5,564 | 18,443 | -89,159 | 22,690 |
| Accounts payable and accrued liabilities | -6,943 | -18,083 | -55,498 | 57,312 | 37,816 |
| Other Working Capital | -88,325 | -12,947 | -189,391 | -174,502 | 42,250 |
| Other Operating Activity | 227,839 | -110,317 | -4,230 | -123,309 | -198,338 |
| Operating Cash Flow | $284,261 | $333,038 | $311,328 | $353,609 | $444,990 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -140,064 | -165,583 | -124,531 | -127,191 | -106,407 |
| Net Acquisitions | 331 | -174,196 | 17,879 | 4,803 | 784,226 |
| Sale Of Investment | N/A | N/A | N/A | 2,961 | 48,248 |
| Purchase Sale Intangibles | -135,050 | -129,256 | -53,411 | -26,912 | -90,367 |
| Other Investing Activity | -147,668 | -166,760 | -86,292 | -22,767 | -89,520 |
| Investing Cash Flow | $-287,402 | $-506,538 | $-192,944 | $-142,194 | $636,548 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 544,388 | 748,358 | 447,760 | 934,886 | 956,354 |
| Debt Repayment | -450,057 | -459,191 | -371,394 | -1,030,494 | -1,961,020 |
| Common Stock Repurchased | -3,747 | -2,996 | -7,670 | -122,191 | -3,260 |
| Dividend Paid | -88,215 | -81,588 | -82,062 | -78,697 | N/A |
| Other Financing Activity | -11,296 | -10,754 | -10,321 | -11,186 | -12,324 |
| Financing Cash Flow | $-8,926 | $193,831 | $-23,688 | $-307,681 | $-1,020,250 |
| Exchange Rate Effect | -32,619 | -34,936 | 47,545 | 31,518 | -39,250 |
| Beginning Cash Position | 397,822 | 400,876 | 280,364 | 391,839 | 366,228 |
| End Cash Position | 353,136 | 386,270 | 422,605 | 327,092 | 388,266 |
| Net Cash Flow | $-44,686 | $-14,606 | $142,241 | $-64,747 | $22,038 |
| Free Cash Flow | |||||
| Operating Cash Flow | 284,261 | 333,038 | 311,328 | 353,609 | 444,990 |
| Capital Expenditure | -141,938 | -166,760 | -125,772 | -129,165 | -133,334 |
| Free Cash Flow | 142,323 | 166,278 | 185,556 | 224,444 | 311,656 |